Breast MRI wins allies, while CAD survives attack
In a flash, after the American Cancer Society guidelines came out in favor of breast MRI for high-risk screening in late March, prominent radiology preauthorization company CareCore proclaimed it had been ahead of the times. The ACS release was a major coup for the technique.
In a flash, after the American Cancer Society guidelines came out in favor of breast MRI for high-risk screening in late March, prominent radiology preauthorization company CareCore proclaimed it had been ahead of the times. The ACS release was a major coup for the technique.
CareCore, which serves more than 30 million subscribers, issued a press release in April indicating that the recommendations were in line with evidence-based policies it had established more than two years ago.
The new ACS guidelines advise annual MRI screening along with mammography for women with a high lifetime risk of breast cancer. They could apply to 1 to 1.5 million women of screening age, and the ACS stamp of approval may impress insurance companies and lead to more uniform acceptance.
Along with the ACS guidelines, breast MRI got a boost earlier in the year when a large multicenter trial found MRI extremely useful in detecting or reliably ruling out mammographically occult cancer in the contralateral breast of women recently diagnosed with cancer in one breast (NEJM 2007;356[13]:1295-1313).
As breast MRI basked in positive publicity, computer-aided detection used in breast imaging came under intense attack with the release of a retrospective study that found CAD resulted in more false positives, recalls, and biopsies and produced lower overall accuracy compared with non-CAD environments (NEJM 2007;356;14:1399-1409).
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Possible Real-Time Adaptive Approach to Breast MRI Suggests ‘New Era’ of AI-Directed MRI
June 3rd 2025Assessing the simulated use of AI-generated suspicion scores for determining whether one should continue with full MRI or shift to an abbreviated MRI, the authors of a new study noted comparable sensitivity, specificity, and positive predictive value for biopsies between the MRI approaches.
